Sanofi to transfer listing to Nasdaq from NYSE

Sanofi announced that it will be transferring the listing of its American depositary shares, or ADS, from the New York Stock Exchange, or NYSE, to The Nasdaq Global Select Market, or Nasdaq, effective December 31, after market close. Sanofi’s ADSs are expected to begin trading as a Nasdaq-listed security at market open on January 2, 2019, and will continue to be listed under the ticker symbol (SNY). This transition will not impact the company’s primary listing on Euronext.
https://thefly.com/landingPageNews.php?id=2838907